TGTX
TG Therapeutics Inc
Price:  
16.48 
USD
Volume:  
3,267,469.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TGTX WACC - Weighted Average Cost of Capital

The WACC of TG Therapeutics Inc (TGTX) is 8.0%.

The Cost of Equity of TG Therapeutics Inc (TGTX) is 8.00%.
The Cost of Debt of TG Therapeutics Inc (TGTX) is 8.60%.

Range Selected
Cost of equity 6.90% - 9.10% 8.00%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.40% - 11.80% 8.60%
WACC 6.8% - 9.1% 8.0%
WACC

TGTX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.66 0.75
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.10%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.04 0.04
Cost of debt 5.40% 11.80%
After-tax WACC 6.8% 9.1%
Selected WACC 8.0%